Activity value 62argentina Supplier,Last transaction date:
2025-05-29
Overview
Export data
Partners
HS Codes
Products
Areas
Ports
Trade trend analysis
Mon
|
Year
Number of TransactionsQuantityWeight
Number of TransactionsQuantityWeight
The above chart presents the market trend analysis for kemex lab from 2024 to 2025.
By examining various dimensions such as transaction quantity, transaction weight, average price,
and transaction frequency, we can gain an intuitive understanding of the company's performance in terms of procurement cycles, business scale, and stability.
As of 2025, the company has completed 4 transactions, with a transaction quantity of 803.37 and a transaction weight of 803.37.
YearTransactionsQuantityWeight
20243516.9516.9
20254803.37803.37
Bill of lading data
<
1/15
>
Trade date
2025/05/29
B/L No.
92003004161686
Suppliers
kemex lab
Buyers
gador s.a.
POLs
——
PODs
bogota
Supply area
Argentina
Purchas area
Colombia
Weight
235.69kg
Amount
54296.7
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
DO 01252331. DECLARACION 1-1 . REG-50096014-20250528N DEL 2025-05-28, VINVIMA-25-0073592 DEL 2025-05-28, NOS ACOGEMOS AL ACUERDO MERCOSUR ENTRE COLOMBIA Y ARGENTINA CON COD. 211, CUMPLE CON LO ESTABLECIDO EN LA NORMA DE ORIGEN ACUERDO ACE72 DE CONFORMIDADCON EL SIGUIENTE DESGLOSE: ANEXO IV, ARTICULO 4 , LITERAL A, CERTIFICADO DE ORIGEN N AR004A72250000026000 DEL 27 05 2025 Y AR004A72250000026100 DEL 27 05 2025.. PRODUCTO: MEDICAMENTO ONCOLOGICO. NOMBRE COMERCIAL: DACARBAZINA 200 MG. PRINCIPIO ACTIVO: DACARBAZINA 200 MG. CONCENTRACION: CADA FRASCO. VIAL CONTIENE DACARBAZINA 200.00 MG. INDICACIONES TERAPEUTICAS: MELANOMA MALIGNO METASTASICO, ENFERMEDAD DE HODKING, SARCOMA DE TEJIDO BLANDO. FORMA FARMACEUTICA: POLVO LIOFILIZADO PARA RECONSTITUIR A SOLUCIONINYECTABLE. TIPO DE EMPAQUE: CAJA X1 FRASCO VIAL DE VIDRIO AMBAR CON FLIP OFF BLANCO. USO: HUMANO. MARCA: DACARBAZINA. FABRICANTE: LABORATORIO KEMEX S.A. UBICACION NAZARRE 3446 54 CIUDAD AUTONOMA DE BUENOS AIRES, PAIS: ARGENTINA, R S: INVIMA 2015M-0016349, EXP
Expand
Trade date
2025/04/21
B/L No.
92003003068950
Suppliers
kemex lab
Buyers
gador s.a.
POLs
——
PODs
bogota
Supply area
Argentina
Purchas area
Colombia
Weight
193.06kg
Amount
52006.3
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
DO 01251588. DECLARACION(1-1). REG-50064652-20250410N DEL 2025-04-10, VINVIMA-25-0049463 DEL 2025-04-09, NOS ACOGEMOS AL
Expand
Trade date
2025/02/27
B/L No.
91003043787224
Suppliers
kemex lab
Buyers
gador s.a.
POLs
——
PODs
bogota
Supply area
Argentina
Purchas area
Colombia
Weight
16.18kg
Amount
10000
Hs code
3004391100
Product tags
medicaments
Product description
DO 01250665. DECLARACION(1-2). REG-50030137-20250218N DEL 2025-02-18, VINVIMA-25-0021733 DEL 2025-02-17.. PRODUCTO: MEDI
Expand
Trade date
2025/02/27
B/L No.
92003001630129
Suppliers
kemex lab
Buyers
gador s.a.
POLs
——
PODs
bogota
Supply area
Argentina
Purchas area
Colombia
Weight
358.44kg
Amount
77383
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
DO 01250665. DECLARACION(2-2). REG-50030137-20250218N DEL 2025-02-18, VINVIMA-25-0021733 DEL 2025-02-17 NOS ACOGEMOS AL
Expand
Trade date
2024/12/23
B/L No.
92003009569929
Suppliers
kemex lab
Buyers
gador s.a.
POLs
——
PODs
bogota
Supply area
Argentina
Purchas area
Colombia
Weight
345.68kg
Amount
66888
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
DO 01245767. DECLARACION(1-1). -PARA TRATAMIENTO ONCOLOGICO O VIH, REG-50215378-20241211N DEL 2024-12-11, VINVIMA-24-0160278 DEL 2024-12-11. NOS ACOGEMOS AL ACUERDO MERCOSUR ENTRE COLOMBIA YARGENTINA CON COD. 211 ACUERDO ACE72, ANEXO IV. ARTICU7LO 4¿ -LITERAL A CERTICADOS DE ORIGEN AR004A72240000099200 DEL 17-12-2024 Y AR004A72240000099300 DEL 17-12-2024. PRODUCTO: MEDICAMENTO ONCOLOGICO. NOMBRE COMERCIAL: DACARBAZINA 200 MG. PRINCIPIO ACTIVO: DACARBAZINA 200 MG. CONCENTRACION: CADA FRASCO. VIAL CONTIENEDACARBAZINA 200.00 MG. INDICACIONES TERAPEUTICAS: MELANOMA MALIGNO METASTASICO, ENFERMEDAD DE HODKING, SARCOMA DE TEJIDO BLANDO. FORMA FARMACEUTICA: POLVO LIOFILIZADO PARA RECONSTITUIR A SOLUCION INYECTABLE. TIPO DE EMPAQUE: CAJA X 1 FRASCO VIAL DE VIDRIOAMBAR CON FLIP OFF BLANCO. USO: HUMANO. MARCA: DACARBAZINA. FABRICANTE: LABORATORIO KEMEX S.A. UBICACION NAZARRE 3446 / 54 CIUDAD AUTONOMA DE BUENOS AIRES, PAIS: ARGENTINA, REGISTRO SANITARIO: INVIMA 2015M-0016349, EXPEDIENTE: 20083480, REGISTRO SANITARIO VIG
Expand
Trade date
2024/11/25
B/L No.
92003008777061
Suppliers
kemex lab
Buyers
gador s.a.
POLs
——
PODs
bogota
Supply area
Argentina
Purchas area
Colombia
Weight
16.18kg
Amount
10000
Hs code
3004391100
Product tags
medicaments
Product description
DO 01245254. DECLARACION(2-2). REG-50202575-20241121N DEL 2024-11-21, VINVIMA-24-0149188 DEL 2024-11-20, NOS ACOGEMOS AL ACUERDO MERCOSUR ENTRE COLOMBIA Y ARGENTINA CON COD. 211, CUMPLE CON LO ESTABLECIDO DE LA NORMA DE ORIGEN ACUERDO ACE72: ANEXO IV, ARTICULO 4驴, LITERAL A, CERTIFICADO DE ORIGEN NO AR004A72240000093800 DEL 19/11/2024. PRODUCTO: MEDICAMENTO ONCOLOGICO. NOMBRE COMERCIAL: FULVESTRANT 250 MG/5ML SOLUCION INYECTABLE. PRINCIPIO ACTIVO: FULVESTRANT 250MG. CONCENTRACION: CADA VIAL X5 ML CONTIENEFULVESTRANT 250 MG. INDICACIONES TERAPEUTICAS: TRATAMIENTO DE MUJERES POSTMENOPAUSICAS CON COCER DE MAMA AVANZADO LOCAL O METASTUSICO, CON RECEPTORES DE ESTR脫GENOS POSITIVOS, QUE PRESENTA UNA RECIDIVA DURANTE O DESPUES DEL TRATAMIENTO ANTIESTROG驴NICO ADVYUVANTE O BIEN UNA PROGRESION DE LA ENFERMEDAD DURANT EL TRATAMIENTO CON UN ANTIESTR脫GENO. FORMA FARMACEUTICA: SH. SOLUCIONES / SOLUCION INYECTABLE. TIPO DE EMPAQUE: YPRESENTACION COMERCIAL: CAJA PLEGADIZA CON 2 VIALES DE 5 ML EN FRASCO DE VIDRIO INCOLOROTIPO
Expand
Trade date
2024/11/25
B/L No.
92003008777077
Suppliers
kemex lab
Buyers
gador s.a.
POLs
——
PODs
bogota
Supply area
Argentina
Purchas area
Colombia
Weight
155.04kg
Amount
25583.8
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
DO 01245254. DECLARACION(1-2). REG-50202575-20241121N DEL 2024-11-21, VINVIMA-24-0149188 DEL 2024-11-20, NOS ACOGEMOS AL ACUERDO MERCOSUR ENTRE COLOMBIA Y ARGENTINA CON COD. 211, CUMPLE CON LO ESTABLECIDO DE LA NORMA DE ORIGEN ACUERDO ACE72: ANEXO IV, ARTICULO 4驴, LITERAL A, CERTIFICADO DE ORIGEN NO AR004A72240000093700 DEL 19/11/2024. PRODUCTO: MEDICAMENTO ONCOLOGICO. NOMBRE COMERCIAL: DACARBAZINA 200 MG. PRINCIPIO ACTIVO: DACARBAZINA 200 MG. CONCENTRACION: CADA FRASCO. VIAL CONTIENE DACARBAZINA 200.00 MG. INDICACIONES TERAPEUTICAS: MELANOMA MALIGNO METASTASICO, ENFERMEDAD DE HODKING, SARCOMA DE TEJIDO BLANDO. FORMA FARMACEUTICA: POLVO LIOFILIZADO PARA RECONSTITUIR A SOLUCION INYECTABLE. TIPO DE EMPAQUE: CAJA X 1 FRASCO VIAL DE VIDRIO AMBAR CON FLIP OFFBLANCO. USO: HUMANO. MARCA: DACARBAZINA. FABRICANTE: LABORATORIO KEMEX S.A. UBICACION NAZARRE 3446 / 54 CIUDAD AUTONOMA DE BUENOS AIRES, PAIS: ARGENTINA, REGISTRO SANITARIO: INVIMA 2015M-0016349, EXPEDIENTE: 20083480, REGISTRO SANITARIO SE VIGENTE, DACARBAZIN
Expand
Trade date
2022/08/26
B/L No.
——
Suppliers
kemex lab
Buyers
gador s.a.
POLs
——
PODs
——
Supply area
China
Purchas area
Colombia
Weight
228.63
Amount
83213.91
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
DO 0122084022. DECLARACION(2-2). REG-50129877-20220824N DEL 2022-08-24, VINVIMA-22-0100688
Expand
Trade date
2022/08/26
B/L No.
——
Suppliers
kemex lab
Buyers
gador s.a.
POLs
——
PODs
——
Supply area
Argentina
Purchas area
Colombia
Weight
31.38kg
Amount
24195.89
Hs code
3004391100
Product tags
medicaments
Product description
FOR ONCOLOGICAL OR HIV TREATMENT
Expand
Trade date
2022/08/26
B/L No.
——
Suppliers
kemex lab
Buyers
gador s.a.
POLs
——
PODs
——
Supply area
Argentina
Purchas area
Colombia
Weight
228.63kg
Amount
83213.91
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
MEDICINES FOR ONCOLOGICAL OR HIV TREATMENT
Expand
Trade date
2022/08/26
B/L No.
——
Suppliers
kemex lab
Buyers
gador s.a.
POLs
——
PODs
——
Supply area
China
Purchas area
Colombia
Weight
31.38
Amount
24195.89
Hs code
3004391100
Product tags
medicaments
Product description
DO 0122084022. DECLARACION(1-2). REG-50129877-20220824N DEL 2022-08-24, VINVIMA-22-0100688
Expand
Trade date
2022/07/14
B/L No.
——
Suppliers
kemex lab
Buyers
gador s.a.
POLs
——
PODs
——
Supply area
China
Purchas area
Colombia
Weight
260.69
Amount
64010.9
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
DO 0122063173. DECLARACION(1-1). REG-50100590-20220706N DEL 2022-07-06, VINVIMA-22-0078409
Expand
Trade date
2022/07/14
B/L No.
——
Suppliers
kemex lab
Buyers
gador s.a.
POLs
——
PODs
——
Supply area
Argentina
Purchas area
Colombia
Weight
260.69kg
Amount
64010.9
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
MEDICINES FOR ONCOLOGICAL OR HIV TREATMENT
Expand
Trade date
2022/06/21
B/L No.
——
Suppliers
kemex lab
Buyers
gador s.a.
POLs
——
PODs
——
Supply area
China
Purchas area
Colombia
Weight
47.95
Amount
39669
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
DO 0122062848. DECLARACION(1-1). REG-50091330-20220615N DEL 2022-06-15, VINVIMA-22-0071300
Expand
Trade date
2022/06/21
B/L No.
——
Suppliers
kemex lab
Buyers
gador s.a.
POLs
——
PODs
——
Supply area
Argentina
Purchas area
Colombia
Weight
47.95kg
Amount
39669
Hs code
3004902400
Product tags
equipped with fixed dose drug
Product description
MEDICINES FOR ONCOLOGICAL OR HIV TREATMENT
Expand
+View All
Partners
Total 2
RankCompanyTransactionsPerDetail
1gador s.a.
argentinabuyer,they trade on 2025-05-29
2555.56%
>
2lab gador s.a.
ecuadorbuyer,they trade on 2020-09-04
2044.44%
>
Products
Total 2
ProductsTransactionsPerDetail
equipped with fixed dose drug 360%>
medicaments 240%>
Hscode rank
Total 4
HSCode NameTransactionsPerDetail
HS 3004902400360%>
HS 3004391100240%>
Trading Area
Total 2
AreaTransactionsPerDetail
colombia2555.56%>
ecuador2044.44%>
Port statistics
Total 2
Port NameTransactionsPerDetail
buenos aires1226.67%>
ezeisa apt buenos aires817.78%>
kemex lab is argentina Supplier,
and primarily engages in the import and export business of products such as equipped with fixed dose drug,medicaments.
According to the 52wmb.com global trade database, as of 2025-05-29, the company has completed 45 international trades,
with its main trading regions covering colombia,ecuador etc.
The core products include HS3004902400,HS3004391100 etc,
often transported via buenos aires,port ezeisa apt buenos aires etc,
and its main trading partners are gador s.a.,lab gador s.a..
These trade data are sourced from various countries' customs and public channels, and have undergone standardization and structuring processing.
They can reflect the import and export trends and main market layout of the enterprise, and are suitable for market trend analysis, competitor research, port transportation planning, supply chain optimization, and international customer development.
They provide reliable support for cross-border trade decision-making.
The trade data displayed on kemex lab is sourced from the 52wmb.com global trade database. It is based on legal records from customs and related public channels of various countries, and has been formatted and organized for user query and analysis.
We maintain compliance with the source and processing of data to ensure the objectivity of information, but due to the dynamic changes in international trade activities, some data may be delayed or changed.